Nippon India Mutual Fund
← All mutual funds

Nippon India Pharma Fund - Direct Plan - Growth Option

Nippon India Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

638.36

1D

-0.22%

1Y

+10.69%

Key stats

Expense ratio
1.00%
AUM
₹9.28 K Cr
Launched
01/01/2013
Fund manager
Sailesh Raj Bhan; Kinjal Desai; Amber Singhania
Portfolio turnover
0.15%
Risk
Very High Risk
Min lump-sum
₹5,000
Min SIP
₹100/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

Nippon India Pharma Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

653.61638.3613/08/202611/09/2026
1W-0.58%
1M-1.39%
3M+5.57%
6M+13.26%
1Y+10.69%
3Y+18.61%
5Y+13.63%
MAX+813.71%

Top holdings

38 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    13.31%
  • 2.

    Lupin Ltd

    Healthcare

    7.25%
  • 3.

    Divi's Laboratories Ltd

    Healthcare

    6.52%
  • 4.

    Cipla Ltd

    Healthcare

    6.03%
  • 5.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    5.30%
  • 6.

    Dr Reddy's Laboratories Ltd

    Healthcare

    5.01%
  • 7.

    Mankind Pharma Ltd

    Healthcare

    3.74%
  • 8.

    Sai Life Sciences Ltd

    Healthcare

    3.62%
  • 9.

    Ajanta Pharma Ltd

    Healthcare

    3.41%
  • 10.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    3.15%
  • 11.

    Medplus Health Services Ltd

    Healthcare

    2.69%
  • 12.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    2.66%
  • 13.

    Ipca Laboratories Ltd

    Healthcare

    2.57%
  • 14.

    Thyrocare Technologies Ltd

    Healthcare

    2.51%
  • 15.

    Vijaya Diagnostic Centre Ltd

    Healthcare

    2.42%
  • 16.

    Abbott India Ltd

    Healthcare

    2.24%
  • 17.

    Triparty Repo

    2.16%
  • 18.

    Gland Pharma Ltd

    Healthcare

    2.16%
  • 19.

    Piramal Pharma Ltd

    Healthcare

    2.09%
  • 20.

    Dr. Lal PathLabs Ltd

    Healthcare

    2.05%
  • 21.

    Alkem Laboratories Ltd

    Healthcare

    2.01%
  • 22.

    Narayana Hrudayalaya Ltd

    Healthcare

    1.80%
  • 23.

    Pfizer Ltd

    Healthcare

    1.65%
  • 24.

    Emcure Pharmaceuticals Ltd

    Healthcare

    1.58%
  • 25.

    Aurobindo Pharma Ltd

    Healthcare

    1.54%
  • 26.

    Syngene International Ltd

    Healthcare

    1.46%
  • 27.

    Fortis Healthcare Ltd

    Healthcare

    1.37%
  • 28.

    Sanofi India Ltd

    Healthcare

    1.07%
  • 29.

    Sanofi Consumer Healthcare India Ltd

    Healthcare

    1.06%
  • 30.

    Suraksha Diagnostic Ltd

    Healthcare

    1.06%
  • 31.

    Akums Drugs and Pharmaceuticals Ltd

    Healthcare

    1.00%
  • 32.

    Anthem Biosciences Ltd

    Healthcare

    0.92%
  • 33.

    Biocon Ltd

    Healthcare

    0.92%
  • 34.

    AstraZeneca Pharma India Ltd

    Healthcare

    0.55%
  • 35.

    Net Current Assets

    0.51%
  • 36.

    Indoco Remedies Ltd

    Healthcare

    0.43%
  • 37.

    Concord Biotech Ltd

    Healthcare

    0.17%
  • 38.

    Cash Margin - Ccil

    0.01%

Sector allocation

  • Healthcare97.32%
  • Unclassified2.68%

Comparable peers

  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+22.13%
    3Y+24.61%
    -

  • Mirae Asset Healthcare Growth Direct Plan

    Mirae Healthcare (G) · ₹3.44 K Cr AUM

    1Y+20.35%
    3Y+23.20%
    -

  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+17.28%
    3Y+24.42%
    -

  • Nippon India Pharma Growth Direct Plan

    Nippon India Pharma (G) · ₹9.28 K Cr AUM

    1Y+11.33%
    3Y+18.83%
    -

  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM

    1Y+9.79%
    3Y+25.46%
    -

Investment objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Scheme details

Scheme code
118759
Fund house
Nippon India Mutual Fund
Category
Open Ended
Type
Equity Schemes
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF204K01I50
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page